Panbela Therapeutics P/E
Cos'è P/E di Panbela Therapeutics?
P/E di Panbela Therapeutics Inc. è 0.00
Qual è la definizione di P/E?
Il rapporto prezzo / utili è il rapporto tra il prezzo delle azioni di una società e l'utile per azione della società calcolato su dodici mesi.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E di aziende nel Health Care settore su NASDAQ rispetto a Panbela Therapeutics
Cosa fa Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Aziende con p/e simili a Panbela Therapeutics
- Rurelec PLC ha P/E di 0.00
- Tomizone ha P/E di 0.00
- Nanogate AG ha P/E di 0.00
- SEL Manufacturing ha P/E di 0.00
- China Zhong Qi Hldgs ha P/E di 0.00
- MedSmart ha P/E di 0.00
- Panbela Therapeutics ha P/E di 0.00
- Epic ha P/E di 0.00
- 2574 ha P/E di 0.00
- GERRY WEBER International AG ha P/E di 0.00
- Houston Nat Res ha P/E di 0.00
- CTPartners Executive Search ha P/E di 0.00
- Crown ElectroKinetics ha P/E di 0.00